Search Clinical Trials
585,889 trials
ID
Status
Phase
Title
Sponsor
NCT07603869
Evaluation of Cardiovascular Risks Among the Participants of the EAPC Congress 2026European Society of CardiologyCompleted
NCT07603869Completed
—
Evaluation of Cardiovascular Risks Among the Participants of the EAPC Congress 2...European Society of Cardi...
NCT07603050
A Phase I/II Clinical Study to Evaluate the Safety and Efficacy of VGN-R08b in Patients With Type III Gaucher's DiseaseShanghai Vitalgen BioPharma Co., Ltd.Not Yet RecruitingPhase 1
NCT07603050Not Yet Recruiting
Phase 1
A Phase I/II Clinical Study to Evaluate the Safety and Efficacy of VGN-R08b in P...Shanghai Vitalgen BioPhar...
NCT07601490
The Effect of Nerve Blocks on Analgesia in Breast Cancer SurgerySultan Abdulhamid Han Training and Research Hospital, Istanbul, TurkeyNot Yet RecruitingNot Applicable
NCT07601490Not Yet Recruiting
Not Applicable
The Effect of Nerve Blocks on Analgesia in Breast Cancer SurgerySultan Abdulhamid Han Tra...
NCT07605195
Research on the Whole-Process Intelligent Diagnosis and Treatment of Digital Breast Tomosynthesis Based on Deep LearningYunnan Cancer HospitalNot Yet RecruitingNot Applicable
NCT07605195Not Yet Recruiting
Not Applicable
Research on the Whole-Process Intelligent Diagnosis and Treatment of Digital Bre...Yunnan Cancer Hospital
NCT07601737
Nimotuzumab Combined With PD-1 Inhibitors and Chemotherapy in the Treatment of Locally Advanced Head and Neck Squamous Cell CarcinomaShanghai General Hospital, Shanghai Jiao Tong University School of MedicineRecruitingPhase 2
NCT07601737Recruiting
Phase 2
Nimotuzumab Combined With PD-1 Inhibitors and Chemotherapy in the Treatment of L...Shanghai General Hospital...
NCT07604038
Oral Supplementation With 1 mg of KGA-10 Daily (a Novel Environmentally-derived Mycolicibacterium) for Stress, Sleep, and InflammationKioga Inc.CompletedNot Applicable
NCT07604038Completed
Not Applicable
Oral Supplementation With 1 mg of KGA-10 Daily (a Novel Environmentally-derived...Kioga Inc.
NCT07604909
A Phase II Randomized Trial of Serplulimab With Second-Line Chemo/Targeted Therapy for Early Relapse Colorectal Cancer After Adjuvant ChemotherapyFudan UniversityRecruitingPhase 2
NCT07604909Recruiting
Phase 2
A Phase II Randomized Trial of Serplulimab With Second-Line Chemo/Targeted Thera...Fudan University
NCT07603622
Perioperative Predictive Value of Physical Activity on Short- and Long-term Morbidity and MortalityKarolinska InstitutetRecruiting
NCT07603622Recruiting
—
Perioperative Predictive Value of Physical Activity on Short- and Long-term Morb...Karolinska Institutet
NCT07602361
Genetic Markers Associated With Capsaicinoid Supplementation Effects in Overweight and ObesityUniversidad Autonoma de Baja CaliforniaActive Not RecruitingNot Applicable
NCT07602361Active Not Recruiting
Not Applicable
Genetic Markers Associated With Capsaicinoid Supplementation Effects in Overweig...Universidad Autonoma de B...
NCT07605117
Isoinertial Training in Patients With COPDUniversidad Manuela BeltránNot Yet RecruitingNot Applicable
NCT07605117Not Yet Recruiting
Not Applicable
Isoinertial Training in Patients With COPDUniversidad Manuela Beltr...
NCT07602036
Type 2 Diabetes and Pregnancy a Single-arm Interventional StudyMedtronicNot Yet RecruitingNot Applicable
NCT07602036Not Yet Recruiting
Not Applicable
Type 2 Diabetes and Pregnancy a Single-arm Interventional StudyMedtronic
NCT07600866
Validation of a Body-Composition Segmentation Software on a Diverse Public CT Scan CohortNucleo Research, Inc.Not Yet Recruiting
NCT07600866Not Yet Recruiting
—
Validation of a Body-Composition Segmentation Software on a Diverse Public CT Sc...Nucleo Research, Inc.
NCT07600853
Development and Validation of an E-learning Module on Systemic Anticancer Therapy and Its Effectiveness on the Knowledge Attitude and Practice of Nurses in Administering Systemic Anticancer Agents at a Specialized Cancer Centres in Oman.Sultan Qaboos Comprehensive Cancer CenterNot Yet RecruitingNot Applicable
NCT07600853Not Yet Recruiting
Not Applicable
Development and Validation of an E-learning Module on Systemic Anticancer Therap...Sultan Qaboos Comprehensi...
NCT07602608
Platelet-Rich Plasma With or Without Tadalafil for Erectile DysfunctionBenha UniversityCompletedPhase 4
NCT07602608Completed
Phase 4
Platelet-Rich Plasma With or Without Tadalafil for Erectile DysfunctionBenha University
NCT07605299
"Comparative Effect of Rolfing Soft Tissue Manipulation and Bowen Technique on Calf Tightness Among Housewives"Rashid Latif Medical CollegeCompletedNot Applicable
NCT07605299Completed
Not Applicable
"Comparative Effect of Rolfing Soft Tissue Manipulation and Bowen Technique on C...Rashid Latif Medical Coll...
NCT07602049
Cryoablation Plus Camrelizumab for Advanced Soft Tissue SarcomaSun Yat-sen UniversityRecruitingPhase 2
NCT07602049Recruiting
Phase 2
Cryoablation Plus Camrelizumab for Advanced Soft Tissue SarcomaSun Yat-sen University
NCT07603232
Long-Term Health Outcomes in Children Born With Hirschsprung's Disease and Anorectal Malformations at the Colorectal Centre of Excellence in QuebecMcGill University Health Centre/Research Institute of the McGill University Health CentreEnrolling By Invitation
NCT07603232Enrolling By Invitation
—
Long-Term Health Outcomes in Children Born With Hirschsprung's Disease and Anore...McGill University Health...
NCT07604766
An Extension Study to Assess the Efficacy of Rina-S Compared to Treatment of Investigator's Choice in Participants With Platinum Resistant Ovarian Cancer in ChinaGenmabNot Yet RecruitingPhase 3
NCT07604766Not Yet Recruiting
Phase 3
An Extension Study to Assess the Efficacy of Rina-S Compared to Treatment of Inv...Genmab
NCT07602530
A Study in Canada to Follow Outcomes of Women in Menopause Treated With Fezolinetant for Hot Flashes, When Given in Clinical PracticeAstellas Pharma Europe Ltd.Recruiting
NCT07602530Recruiting
—
A Study in Canada to Follow Outcomes of Women in Menopause Treated With Fezoline...Astellas Pharma Europe Lt...
Result Breakdown
Not yet recruiting9 (45%)
Recruiting5 (25%)
Completed4 (20%)
Active, not recruiting1 (5%)
Enrolling by invitation1 (5%)
not_applicable9 (45%)
Not Specified5 (25%)
Phase 23 (15%)
Phase 11 (5%)
Phase 41 (5%)
Phase 31 (5%)